Prenatal screens:  Maternal blood type A positive, antibody negative, Rubella immune, RPR nonreactive, hepatitis B surface antigen negative and Group B Streptococcus status unknown.
Ultrasound showed no structural defects.
Apgars scores were 5 at one minute and 7 at five minutes of age.
PHYSICAL EXAMINATION ON ADMISSION:  Weight 510 gm (less than 10th percentile), length 30 cm (less than 10th percentile), head circumference 22.5 cm (less than 10th percentile).
Vital signs, temperature 95.7, heart rate 146, respiratory rate 70, oxygen saturation 84%, blood pressure 49/30 with a mean arterial pressure of 41.
Initial D-stick was 7, quickly increased to 44 with D10 boluses.
Head, ears, eyes, nose and throat were all normal.
(Although chest x-ray showed endotracheal tube to be slightly high, but then repositioned.)
Sputum cultures at this time were positive for proteus mirabilis and Stenotrophomonas.
Chest x-ray showed diffuse patchy infiltrates.
He respiratory rate ranges from 30 to 60 and she is maintaining her oxygen saturations in the mid 90s.
Cardiovascular - [**Known lastname 51821**] blood pressure has been stable throughout her hospitalization.
An echocardiogram on [**8-9**] showed a patent ductus arteriosus and she received a course of Indomethacin on day of life #3.
Subsequent echocardiograms confirmed patent ductus arteriosus closure.
Because of her severe chronic lung disease, an echocardiogram was performed on [**11-28**], results showed right ventricular pressures less than half of systemic pressure, trace tricuspid regurgitation, and good biventricular function.
Fluids, electrolytes and nutrition - Intravenous fluids of D10/W at 120 cc/kg/day were started upon admission to the Newborn Intensive Care Unit.
Her electrolytes have been normal during her hospitalization.
Her last set of electrolytes on [**11-24**] were sodium of 140, potassium 4.8, chloride 101, and bicarbonate of 28.
Discharge weight 2.87 kg .
Gastrointestinal - Phototherapy was started on day of life #1 for a peak bilirubin of 4.5.
Phototherapy was discontinued on day of life #7 with a rebound bilirubin of 2.0 on day of life #8.
Heme - [**Known lastname 51821**] blood type is A positive.
She received a platelet transfusion on day of life #3 for a platelet count of 68,000.
Her last hematocrit and reticulocyte count on [**11-27**] were 32.5 and 3.9.
Infectious disease - A complete blood count with differential and a blood culture were drawn upon admission to the Newborn Intensive Care Unit.
[**Known lastname 38492**] had a white count of 3.5, hematocrit of 52.7, platelet count of 335 with 23% polys and 0% bands.
Blood culture at that time was negative.
Her complete blood count at that time showed a white count of 18, hematocrit of 44, platelet count of 283 with 38% polys and 4% bands.
Blood culture at that time was negative but trach aspirate was positive for Proteus mirabilis and Stenotrophomonas.
Her lumbar puncture at that time was unremarkable and cerebrospinal fluid culture was negative.
Blood culture at that time was positive for Streptococcus A which was felt to be a contaminate.
Sensory - Audiology, a hearing screen was performed with an automated auditory brain stem responses.
A follow up examination is recommended in nine months.
Medications - 1.
Carseat test - [**Known lastname 38492**] had a carseat test, she passed on [**11-30**].
State newborn screening - The last newborn screen was sent on [**10-16**], no abnormal results have been reported.
Follow up appointments - [**First Name8 (NamePattern2) 2270**] [**Last Name (NamePattern1) 37303**], primary pediatrician on [**12-9**]; Ophthalmology with Dr. [**Last Name (STitle) **] for follow up eye examination at nine months; [**First Name4 (NamePattern1) 4468**] [**Last Name (NamePattern1) 37305**] Pulmonology, follow up in two weeks.
Care Group [**Hospital6 407**], phone #[**Telephone/Fax (1) 37503**], fax [**Telephone/Fax (1) 38333**].
[**Hospital1 **] [**First Name (Titles) **] [**Last Name (Titles) **] Intervention Program, [**Hospital1 2436**], phone #[**Telephone/Fax (1) 37505**], fax [**Telephone/Fax (1) 37506**].
Prematurity at 27 6/7 weeks 2.
Intrauterine growth retardation 3.
[**MD Number(1) 35941**]  Dictated By:[**Name8 (MD) 37391**] MEDQUIST36  D:  [**2127-11-30**]  17:44 T:  [**2127-11-30**]  17:57 JOB#:  [**Job Number 51823**]
